Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

Takeda and Innovent Biologics Enter Collaboration Agreement on IBI343 and IBI363 Cancer Drugs

Posted by author-avatar
0
Test Logo Transparent

Last week, Takeda announced that it has entered into a worldwide license and collaboration agreement (outside of Greater China) with Innovent Biologics for the development, manufacture, and commercialization of two late-stage oncology medicines, IBI363 and IBI343….
By: Goodwin

Newer
Another Day, Another Fake MAGA Prosecutor
Back to list
Older District court grants final approval to class action after data breach

Leave a Reply

Your email address will not be published. Required fields are marked *